|Series A, 7/2010 |
Beringea Private Equity
North Coast Technology Investors
|Series B, 9/2013 ||$11M|
Delphinus Medical Technologies, LLC develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women’s breasts for the presence of benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan.